| X23-10-ZQ1027 |
EGFR-HER2 inhibitor AEE788, Purity ≥98%
|
|
| X23-10-ZQ1028 |
EGFR-HER2 inhibitor Tyrphostin AG 879, Purity ≥98%
|
|
| X23-10-ZQ1029 |
EGFR-HER2 inhibitor AST-6, Purity ≥98%
|
|
| X23-10-ZQ1030 |
EGFR-HER2 inhibitor AZD8931, Purity ≥98%
|
|
| X23-10-ZQ1031 |
EGFR-HER2 inhibitor BIBW2992, Purity ≥98%
|
|
| X23-10-ZQ1033 |
EGFR-HER2 inhibitor Canertinib, Purity ≥98%
|
|
| X23-10-ZQ1034 |
EGFR-HER2 inhibitor CP-724714, Purity ≥98%
|
|
| X23-10-ZQ1035 |
EGFR-HER2 inhibitor Erlotinib HCl, Purity ≥98%
|
|
| X23-10-ZQ1036 |
EGFR-HER2 inhibitor Gefitinib, Purity ≥98%
|
|
| X23-10-ZQ1038 |
EGFR-HER2 inhibitor Lapatinib ditosylate, Purity ≥98%
|
|
| X23-10-ZQ1039 |
EGFR-HER2 inhibitor Mubritinib, Purity ≥98%
|
|
| X23-10-ZQ1040 |
EGFR-HER2 inhibitor Neratinib, Purity ≥98%
|
|
| X23-10-ZQ1041 |
EGFR-HER2 inhibitor OSI-420, Purity ≥98%
|
|
| X23-10-ZQ1042 |
EGFR-HER2 inhibitor PD153035, Purity ≥98%
|
|
| X23-10-ZQ1043 |
EGFR-HER2 inhibitor Pelitinib, Purity ≥98%
|
|
| X23-10-ZQ1044 |
EGFR-HER2 inhibitor WZ3146, Purity ≥98%
|
|
| X23-10-ZQ1045 |
EGFR-HER2 inhibitor WZ4002, Purity ≥98%
|
|
| X23-10-ZQ1046 |
EGFR-HER2 inhibitor WZ8040, Purity ≥98%
|
|
| X23-10-ZQ1047 |
EGFR-HER2 inhibitor AG-1478, Purity ≥98%
|
|
| X23-10-ZQ1048 |
EGFR-HER2 inhibitor Arry-380 analog, Purity ≥98%
|
|
